Genetic variation and hematology: single-nucleotide polymorphisms, haplotypes, and complex disease.
In the course of generating a draft sequence of the human genome, we now recognize the enormous scope of genetic variation among humans, which can be used to probe the genetics of complex diseases such as leukemia or thrombosis. There is already mounting evidence of new susceptibility genes and genes that interact with environmental factors. Genetic variants, especially single-nucleotide polymorphisms (SNPs), also can be utilized to investigate potential modifiers of disease. Genetic variation can be applied to study pharmacogenomics, which could eventually drive the choice of therapeutic and interventional strategies. The genomic revolution ultimately should give insights into key mechanisms in hematological disorders that can be translated into targeted therapies.
Section on Genomic Variation, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4605, USA.
Stephen
S
Chanock
D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006239:Haplotypes; D006402:Hematologic Diseases / Q000235:genetics*; D006801:Humans; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide